Additionally, given the roles of CHEK2 and APC in key cellular pathways, targeted therapies that aim to restore normal function in these pathways could hold promise for the management of secondary thyroid cancer in childhood cancer survivors [30]. Here, CHEK2 is linked to childhood malignant neoplasm.